To screen or not to screen women in their 40s for breast cancer: Is personalized risk-based screening the answer?

Annals of Internal Medicine

Volumn 155, Issue 1, 2011, Pages 58-60

  Mandelblatt, Jeanne S ^a   Stout, Natasha ^b   Trentham Dietz, Amy ^c  

^a GEORGETOWN UNIVERSITY   (United States)

^b HARVARD PILGRIM HEALTH CARE INSTITUTE   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BREAST CANCER; CANCER RISK; CANCER SCREENING; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DIAGNOSTIC IMAGING; DIGITAL MAMMOGRAPHY; EDITORIAL; FALSE POSITIVE RESULT; FEMALE; HEALTH CARE COST; HUMAN; MAMMOGRAPHY; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; X RAY FILM;

EID: 79960063524     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-155-1-201107050-00008     Document Type: Editorial

References (19)

1. Qaseem A, Snow V, Sherif K, Aronson M, Weiss KB, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007;146: 511-5
2. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 151:716-26, W-236.
3. Hendrick RE, Helvie MA. United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR Am J Roentgenol. 2011;196:W112-6.
4. Kolata G. Panel urges mammograms at 50, not 40. New York Times. 16 November 2009. Accessed at www.nytimes.com/2009/11/17/health/17cancer.html on 25 May 2011.
5. Sargenti S, Dresdale A. Celeb survivors protest breast cancer screening guidelines. ABC News. 18 November 2009. Accessed at http://abcnews.go.com/Health/OnCallPlusBreastCancerNews/celeb-survivors-rail-breast-cancer-screening-guidelines-olivia/story?id=9128759 on 25 May 2011.
6. Taranto J. Death panels already? Wall Street Journal. 17 November 2009. Accessed at http://online.wsj.com/article/SB10001424052748704782304574541833250894194.html on 25 May 2011.
7. Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011;155:10-20.
8. Gail M, Rimer B. Risk-based recommendations for mammographic screening for women in their forties. J Clin Oncol. 1998;16:3105-14.
9. Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, et al; Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151:738-47.
10. Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S. Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst. 2010; 102:1224-37.
11. Aiello EJ, Buist DS, White E, Porter PL. Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2005;14:662-8.
12. Ma H, Luo J, Press MF, Wang Y, Bernstein L, Ursin G. Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomarkers Prev. 2009;18:479-85.
13. Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:2090-5.
14. Conroy SM, Pagano I, Kolonel LN, Maskarinec G. Mammographic density and hormone receptor expression in breast cancer: The Multiethnic Cohort Study. Cancer Epidemiol. 2011.
15. Martin LJ, Boyd NF. Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res. 2008;10:201.
16. Chiu SY, Duffy S, Yen AM, Tabár L, Smith RA, Chen HH. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev. 2010;19:1219-28.
17. Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith- Bindman R, et al; National Institutes of Health Breast Cancer Surveillance Consortium. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst. 2007;99:386-95.
18. U.S. Food and Drug Administration. Mammography Quality and Standards Act National Statistics. Silver Spring, MD: U.S. Food and Drug Administration; 2011. Accessed at www.fda.gov/Radiation-EmittingProducts/MammographyQualityStandardsActandProgram/FacilityScorecard/ucm113858.htm on 25 May 2011.
19. Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, et al; Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group. Diagnostic performance of digital versus film mammography for breastcancer screening. N Engl J Med. 2005;353:1773-83.